Healthcare CRM Market Size, Share & Trends Analysis Report By Functionality, By Deployment Mode (On-premise Model, Cloud/Web-based Model), By End-use, By AI-Powered Healthcare CRM, By Region, And Segment Forecasts, 2024 - 2030
Healthcare CRM Market Growth & Trends
The global healthcare CRM market size is anticipated to reach USD 30.65 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The adoption of customer relationship management (CRM) in healthcare organizations streamlines workflows and enhances patient care while reducing costs and improving efficiency. The global COVID-19 pandemic underscored the urgent need for digitized interoperability solutions to deliver faster and more effective results. The increasing adoption of Electronic Health Records (EHR) in both developed and developing economies is also expected to fuel significant growth in this market. Key drivers for the industry growth include the rising geriatric population, incidence of chronic diseases, and advancements in technology. The demand for operational efficiency, adoption of home care/virtual care, and the emergence of big data further contribute to market growth.
For example, in September 2023, NHS Digital (England) reported that 4,878 practices conducted at least one online consultation, with approximately 2.4 million patient submissions received, of which 1.6 million were clinical. Market players adopt strategies, such as new product launches and forming collaborations, partnerships, and engaging in mergers and acquisitions to strengthen their position. For instance, in October 2022, Fujitsu partnered with Salesforce Japan Co., Ltd. to introduce digital solutions in the healthcare industry, leveraging Fujitsu's expertise in managing pharmaceutical and medical data and computing technologies along with Salesforce Japan's CRM proficiency. Similarly, in August 2021, Zoho Corp. unveiled Canvas Zoho CRM, a creative studio for CRM customization designed to simplify the user experience and increase CRM adoption rates.
Healthcare CRM Market Report Highlights
- The market was valued at USD 17.87 billion in 2023 and is expected to grow at a CAGR of 7.7% during the forecast period
- Based on functionality, the sales segment dominated the market in 2023 while it is also anticipated to be the fastest growing segment from 2024 to 2030. This is owing to the growing number of solutions available in the market and initiatives implemented by leading companies
- Based on deployment mode, the cloud/ web-based model held the largest share in 2023. It is also projected to grow at the fastest CAGR during the forecast period
- The healthcare providers segment accounted for the highest share of 40.21% in 2023.The healthcare payers segment, on the other hand, is estimated to grow at the fastest CAGR from 2024 to 2030
- North America dominated the global market with a share of 58.0% in 2023. On the other hand, Asia Pacific is expected to register the fastest CAGR from 2024 to 2030 owing to the changing healthcare system and demand for collaborative care
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Component
- 1.1.2. Functionality
- 1.1.3. Deployment Mode
- 1.1.4. End Use
- 1.1.5. AI-Powered Healthcare CRM
- 1.1.6. Regional scope
- 1.1.7. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component outlook
- 2.2.2. Functionality outlook
- 2.2.3. Deployment mode outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Healthcare CRM Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Integration of AI/ML in the healthcare industry
- 3.2.1.2. Demand for a better customer experience
- 3.2.2. Market restraint analysis
- 3.2.2.1. High implementation cost
- 3.2.2.2. Data Security risk
- 3.3. Healthcare CRM Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. COVID-19 Impact
- Chapter 4. Healthcare CRM Market: Component Estimates & Trend Analysis
- 4.1. Component Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Healthcare CRM Market by Component Outlook
- 4.4. Software
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Services
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. Healthcare CRM Market: Functionality Estimates & Trend Analysis
- 5.1. Functionality Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Healthcare CRM Market by Functionality Outlook
- 5.4. Customer Service and Support
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Digital Commerce
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Marketing
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.7. Sales
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.8. Cross -CRM
- 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. Healthcare CRM Market: Deployment Mode Estimates & Trend Analysis
- 6.1. Deployment Mode Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Healthcare CRM Market by Deployment Mode Outlook
- 6.4. On-premise Model
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Cloud/Web-based Model
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 7. Healthcare CRM Market: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. Global Healthcare CRM Market by End-use Outlook
- 7.4. Healthcare Providers
- 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 7.5. Healthcare Payers
- 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 7.6. Life Sciences Industry
- 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 8. Healthcare CRM Market: AI-Powered Healthcare CRM Estimates & Trend Analysis
- 8.1. AI-Powered Healthcare CRM Market Share, 2023 & 2030
- 8.2. Technology Trend Analysis
- 8.3. Case Study
- Chapter 9. Healthcare CRM Market: Regional Estimates & Trend Analysis, By Component, By Functionality, By Deployment Mode, By End Use, By AI-Powered Healthcare CRM
- 9.1. Regional Market Share Analysis, 2023 & 2030
- 9.2. Regional Market Dashboard
- 9.3. Global Regional Market Snapshot
- 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 9.5. North America
- 9.5.1. U.S.
- 9.5.1.1. Key country dynamics
- 9.5.1.2. Regulatory framework/ reimbursement structure
- 9.5.1.3. Competitive scenario
- 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.2. Canada
- 9.5.2.1. Key country dynamics
- 9.5.2.2. Regulatory framework/ reimbursement structure
- 9.5.2.3. Competitive scenario
- 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6. Europe
- 9.6.1. UK
- 9.6.1.1. Key country dynamics
- 9.6.1.2. Regulatory framework/ reimbursement structure
- 9.6.1.3. Competitive scenario
- 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.2. Germany
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Regulatory framework/ reimbursement structure
- 9.6.2.3. Competitive scenario
- 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.3. France
- 9.6.3.1. Key country dynamics
- 9.6.3.2. Regulatory framework/ reimbursement structure
- 9.6.3.3. Competitive scenario
- 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.4. Italy
- 9.6.4.1. Key country dynamics
- 9.6.4.2. Regulatory framework/ reimbursement structure
- 9.6.4.3. Competitive scenario
- 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.5. Spain
- 9.6.5.1. Key country dynamics
- 9.6.5.2. Regulatory framework/ reimbursement structure
- 9.6.5.3. Competitive scenario
- 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.6. Norway
- 9.6.6.1. Key country dynamics
- 9.6.6.2. Regulatory framework/ reimbursement structure
- 9.6.6.3. Competitive scenario
- 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.7. Sweden
- 9.6.7.1. Key country dynamics
- 9.6.7.2. Regulatory framework/ reimbursement structure
- 9.6.7.3. Competitive scenario
- 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.8. Denmark
- 9.6.8.1. Key country dynamics
- 9.6.8.2. Regulatory framework/ reimbursement structure
- 9.6.8.3. Competitive scenario
- 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7. Asia Pacific
- 9.7.1. Japan
- 9.7.1.1. Key country dynamics
- 9.7.1.2. Regulatory framework/ reimbursement structure
- 9.7.1.3. Competitive scenario
- 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.2. China
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Regulatory framework/ reimbursement structure
- 9.7.2.3. Competitive scenario
- 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.3. India
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Regulatory framework/ reimbursement structure
- 9.7.3.3. Competitive scenario
- 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.4. Australia
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Regulatory framework/ reimbursement structure
- 9.7.4.3. Competitive scenario
- 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.5. South Korea
- 9.7.5.1. Key country dynamics
- 9.7.5.2. Regulatory framework/ reimbursement structure
- 9.7.5.3. Competitive scenario
- 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.6. Thailand
- 9.7.6.1. Key country dynamics
- 9.7.6.2. Regulatory framework/ reimbursement structure
- 9.7.6.3. Competitive scenario
- 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8. Latin America
- 9.8.1. Brazil
- 9.8.1.1. Key country dynamics
- 9.8.1.2. Regulatory framework/ reimbursement structure
- 9.8.1.3. Competitive scenario
- 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.2. Mexico
- 9.8.2.1. Key country dynamics
- 9.8.2.2. Regulatory framework/ reimbursement structure
- 9.8.2.3. Competitive scenario
- 9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.3. Argentina
- 9.8.3.1. Key country dynamics
- 9.8.3.2. Regulatory framework/ reimbursement structure
- 9.8.3.3. Competitive scenario
- 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9. MEA
- 9.9.1. South Africa
- 9.9.1.1. Key country dynamics
- 9.9.1.2. Regulatory framework/ reimbursement structure
- 9.9.1.3. Competitive scenario
- 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.2. Saudi Arabia
- 9.9.2.1. Key country dynamics
- 9.9.2.2. Regulatory framework/ reimbursement structure
- 9.9.2.3. Competitive scenario
- 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.3. UAE
- 9.9.3.1. Key country dynamics
- 9.9.3.2. Regulatory framework/ reimbursement structure
- 9.9.3.3. Competitive scenario
- 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.4. Kuwait
- 9.9.4.1. Key country dynamics
- 9.9.4.2. Regulatory framework/ reimbursement structure
- 9.9.4.3. Competitive scenario
- 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.3. Key company market share analysis, 2023
- 10.4. Company Profiles
- 10.4.1. Microsoft
- 10.4.1.1. Company overview
- 10.4.1.2. Financial performance
- 10.4.1.3. Product benchmarking
- 10.4.1.4. Strategic initiatives
- 10.4.2. Cerner Corporation (Oracle)
- 10.4.2.1. Company overview
- 10.4.2.2. Financial performance
- 10.4.2.3. Product benchmarking
- 10.4.2.4. Strategic initiatives
- 10.4.3. IBM
- 10.4.3.1. Company overview
- 10.4.3.2. Financial performance
- 10.4.3.3. Product benchmarking
- 10.4.3.4. Strategic initiatives
- 10.4.4. SAP
- 10.4.4.1. Company overview
- 10.4.4.2. Financial performance
- 10.4.4.3. Product benchmarking
- 10.4.4.4. Strategic initiatives
- 10.4.5. Accenture
- 10.4.5.1. Company overview
- 10.4.5.2. Financial performance
- 10.4.5.3. Product benchmarking
- 10.4.5.4. Strategic initiatives
- 10.4.6. Zoho Corporation
- 10.4.6.1. Company overview
- 10.4.6.2. Financial performance
- 10.4.6.3. Product benchmarking
- 10.4.6.4. Strategic initiatives
- 10.4.7. hc1
- 10.4.7.1. Company overview
- 10.4.7.2. Financial performance
- 10.4.7.3. Product benchmarking
- 10.4.7.4. Strategic initiatives
- 10.4.8. LeadSquared
- 10.4.8.1. Company overview
- 10.4.8.2. Financial performance
- 10.4.8.3. Product benchmarking
- 10.4.8.4. Strategic initiatives
- 10.4.9. Salesforce
- 10.4.9.1. Company overview
- 10.4.9.2. Financial performance
- 10.4.9.3. Product benchmarking
- 10.4.9.4. Strategic initiatives
- 10.4.10. Veeva Systems
- 10.4.10.1. Company overview
- 10.4.10.2. Financial performance
- 10.4.10.3. Product benchmarking
- 10.4.10.4. Strategic initiatives
- 10.4.11. Talisma
- 10.4.11.1. Company overview
- 10.4.11.2. Financial performance
- 10.4.11.3. Product benchmarking
- 10.4.11.4. Strategic initiatives
- 10.4.12. Alvaria
- 10.4.12.1. Company overview
- 10.4.12.2. Financial performance
- 10.4.12.3. Product benchmarking
- 10.4.12.4. Strategic initiatives
- 10.4.13. NICE
- 10.4.13.1. Company overview
- 10.4.13.2. Financial performance
- 10.4.13.3. Product benchmarking
- 10.4.13.4. Strategic initiatives
- 10.4.14. Verint Systems Inc.
- 10.4.14.1. Company overview
- 10.4.14.2. Financial performance
- 10.4.14.3. Product benchmarking
- 10.4.14.4. Strategic initiatives
- 10.4.15. Creatio
- 10.4.15.1. Company overview
- 10.4.15.2. Financial performance
- 10.4.15.3. Product benchmarking
- 10.4.15.4. Strategic initiatives
- 10.4.16. Cured (Acquired by Innovaccer Inc.)
- 10.4.16.1. Company overview
- 10.4.16.2. Financial performance
- 10.4.16.3. Product benchmarking
- 10.4.16.4. Strategic initiatives
- 10.4.17. Actium Health
- 10.4.17.1. Company overview
- 10.4.17.2. Financial performance
- 10.4.17.3. Product benchmarking
- 10.4.17.4. Strategic initiatives
- 10.4.18. Keona Health
- 10.4.18.1. Company overview
- 10.4.18.2. Financial performance
- 10.4.18.3. Product benchmarking
- 10.4.18.4. Strategic initiatives
- 10.4.19. MediCRM.ai
- 10.4.19.1. Company overview
- 10.4.19.2. Financial performance
- 10.4.19.3. Product benchmarking
- 10.4.19.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook